SkinBioTherapeutics (LON:SBTX) Shares Down 9.5%

SkinBioTherapeutics plc (LON:SBTX)’s share price dropped 9.5% during trading on Tuesday . The stock traded as low as GBX 10.75 ($0.14) and last traded at GBX 10.75 ($0.14). Approximately 1,266,880 shares changed hands during mid-day trading, an increase of 59% from the average daily volume of 797,620 shares. The stock had previously closed at GBX 11.88 ($0.16).

SkinBioTherapeutics Stock Performance

The company has a quick ratio of 10.01, a current ratio of 6.57 and a debt-to-equity ratio of 2.66. The business has a 50 day moving average price of GBX 11.96 and a two-hundred day moving average price of GBX 10.31. The stock has a market cap of £24.30 million, a P/E ratio of -593.75 and a beta of 2.01.

About SkinBioTherapeutics

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.